The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $67.26

Today's change+0.16 +0.24%
Updated March 29 4:15 PM EDT. Delayed by at least 15 minutes.
 

Gilead Sciences Inc

Nasdaq: GILD
Last

(U.S.) $67.26

Today's change+0.16 +0.24%
Updated March 29 4:15 PM EDT. Delayed by at least 15 minutes.

Gilead Sciences Inc up (U.S.)$0.16

Gilead Sciences Inc closed up Wednesday by (U.S.)$0.16 or 0.24% to (U.S.)$67.26. Over the last five days, shares have lost 0.84% and sit 2.88% above their 52-week low. This security has underperformed the S&P 500 by 41.95% during the last year.

Key company metrics

  • Open(U.S.) $67.10
  • Previous close(U.S.) $67.10
  • High(U.S.) $67.57
  • Low(U.S.) $66.91
  • Bid / Ask(U.S.) $67.27 / (U.S.) $67.35
  • YTD % change-6.07%
  • Volume7,224,725
  • Average volume (10-day)7,913,942
  • Average volume (1-month)9,147,143
  • Average volume (3-month)10,002,509
  • 52-week range(U.S.) $65.38 to (U.S.) $103.10
  • Beta1.15
  • Trailing P/E6.77×
  • P/E 1 year forward8.14×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.08
  • Dividend yield3.09%
  • Trailing EPS(U.S.) $9.94
Updated March 29 4:15 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.38%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue7,3207,5007,7767,794
Total other revenue--------
Total revenue7,3207,5007,7767,794
Gross profit6,2456,3716,9126,601
Total cost of revenue1,0751,1298641,193
Total operating expense3,2753,1013,2383,143
Selling / general / administrative992831890685
Research & development1,2081,1411,4841,265
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income4,0454,3994,5384,651
Interest income (expense), net non-operating-265-242-227-230
Gain (loss) on sale of assets--------
Other--------
Income before tax3,9204,2764,3994,502
Income after tax3,0993,3253,4973,567
Income tax, total821951902935
Net income3,1083,3303,4973,566
Total adjustments to net income--------
Net income before extra. items3,1083,3303,4973,566
Minority interest950-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,1083,3303,4973,566
Inc. avail. to common incl. extra. items3,1083,3303,4973,566
Diluted net income3,1083,3303,4973,566
Dilution adjustment0000
Diluted weighted average shares1,3251,3391,3551,412
Diluted EPS excluding extraordinary itemsvalue per share2.352.492.582.53
Dividends per sharevalue per share0.470.470.470.43
Diluted normalized EPSvalue per share2.352.492.582.53